What this ETF is trying to do

The Amplify Weight Loss Drug & Treatment ETF (ticker: THNR) focuses on companies involved in weight loss drugs and treatments. Instead of buying just one company, this ETF holds a variety of different businesses in that specific field.

Top Holdings:

• ELI LILLY AND CO (10.31%)

• NOVO NORDISK AS ADR (8.51%)

• AMGEN INC (5.78%)

• CSPC PHARMACEUTICAL GROUP LTD (5.48%)

• PFIZER INC (5.42%)

• ASTRAZENECA PLC (5.37%)

• GILEAD SCIENCES INC (5.30%)

• ABBVIE INC (5.24%)

• MERCK & CO INC (5.23%)

• INNOVENT BIOLOGICS INC (5.18%)

What the numbers show

As of October 6, 2026, the current price of one share is $24.49. An estimated price from roughly one year ago was $24.82.

When looking at how the ETF performed over the last year, there are two different numbers to notice:

• One-year price return: -1.32%. This measures only the change in the share price.

• One-year total return: 0.29%. This includes both the share price change and any cash distributions paid out.

For the current year so far (Year-to-Date), both the price return and the total return are -2.88%.

Income and distribution explanation

Some investors look for "distributions," which are cash payments made by the ETF. This ETF has a distribution yield of approximately 1.69%. However, these payments are described as "irregular" or "less frequent."

It is important to remember that a distribution yield is not the same as a total return. While distributions provide cash, they do not guarantee that your original investment will stay the same value. In this case, the one-year total return (0.29%) was higher than the price return (-1.32%), which shows how distributions can affect the overall result.

NAV erosion explanation

"NAV erosion" refers to a decline in the value of the underlying assets that the ETF owns. StockValueFinder uses an "erosion-risk score" to measure how stable an ETF is.

THNR has an erosion score of 94, which is labeled as "Stable / sideways." The severity of this risk is rated as "good," and there is no severe erosion-risk flag for this ETF.

Pros

• Sector Focus: It provides exposure to the specific field of weight loss treatments.

• Stability Score: The erosion-risk score suggests the fund's value has been relatively stable or moving sideways rather than dropping sharply.

Cons

• Negative YTD Returns: Both the price and total returns have been negative so far this year.

• Irregular Income: Distributions do not happen on a regular, predictable schedule.

Beginner takeaway

When looking at THNR, it is helpful to distinguish between the share price and the total return. While the share price itself went down over the last year, the total return was slightly positive because of the cash distributions. Always look at both numbers to get the full picture of how an ETF is performing.